de Langen C D, Hanich R F, Michelson E L, Kadish A H, Levine J H, Balke C W, Spear J F, Moore E N
Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia 19104.
J Am Coll Cardiol. 1988 Feb;11(2):403-13. doi: 10.1016/0735-1097(88)90109-x.
Twenty-eight anesthetized mongrel dogs were studied 2 to 74 months after experimental myocardial infarction in order to examine the effects of procainamide, lidocaine and acetylstrophanthidin on conduction within the infarcted region and the way such effects relate to changes in body surface potentials and antiarrhythmic efficacy. In each animal, 100 to 200 QRS complexes in the X, Y, Z leads were signal averaged, vector summed and high pass filtered at 50 Hz. Susceptibility to ventricular arrhythmia was evaluated using routine programmed ventricular extrastimulation in the anesthetized open chest animal. Epicardial electrograms were sequentially recorded at 45 standard sites within the infarcted region and referenced to the beginning of the QRS complex. Of the three agents, only procainamide exhibited antiarrhythmic action whereas lidocaine and acetylstrophanthidin produced inconsistent effects. Procainamide prolonged the time at which activity in the epicardial electrographic recordings ended relative to the beginning of the body surface QRS complex. This effect was significantly greater in electrograms that ended late in the QRS complex in the control state than for those that ended earlier. Such preferential effect on more abnormal sites was reflected on the body surface as a greater effect of procainamide in prolonging the lower energy terminal portion of the signal-averaged QRS complex than the earlier high energy portion. In contrast, lidocaine significantly prolonged the time at which electrograms ended only for those relatively normal electrograms that ended early in the QRS complex in the control state. In the signal-averaged body surface QRS complex, lidocaine produced a small but significant prolongation of the early high energy portion of the QRS complex but no change in the late portion. Acetylstrophanthidin produced a significant prolongation in early-ending electrograms and, surprisingly, significantly shortened the end time of electrograms that ended late in the QRS complex in the control state. Such effects were not reflected, however, on the body surface because acetylstrophanthidin had no significant effect on either the early or the late portion of the QRS complex. It is concluded that procainamide's differential effect between early- and late-ending electrograms is detected on the body surface by a greater prolongation in the terminal portion of the QRS complex. The signal-averaged body surface QRS complex is less sensitive in detecting the more subtle effects on conduction caused by lidocaine and acetylstrophanthidin.(ABSTRACT TRUNCATED AT 400 WORDS)
为了研究普鲁卡因胺、利多卡因和毒毛花苷对梗死区域内传导的影响,以及这些影响与体表电位变化和抗心律失常疗效之间的关系,对28只实验性心肌梗死后2至74个月的麻醉杂种犬进行了研究。在每只动物中,对X、Y、Z导联中的100至200个QRS复合波进行信号平均、向量求和,并在50Hz进行高通滤波。在麻醉的开胸动物中,使用常规程控心室额外刺激来评估室性心律失常的易感性。在梗死区域内的45个标准部位顺序记录心外膜电图,并以QRS复合波的起始点为参考。在这三种药物中,只有普鲁卡因胺表现出抗心律失常作用,而利多卡因和毒毛花苷产生的效果不一致。普鲁卡因胺延长了心外膜电图记录中的活动相对于体表QRS复合波起始点结束的时间。在对照状态下,QRS复合波中结束较晚的电图中,这种效应明显大于结束较早的电图。对更多异常部位这种优先作用在体表表现为,普鲁卡因胺对信号平均QRS复合波较低能量的终末部分的延长作用大于较早的高能量部分。相比之下,利多卡因仅对对照状态下QRS复合波中结束较早的那些相对正常的电图,显著延长了其结束时间。在信号平均的体表QRS复合波中,利多卡因使QRS复合波的早期高能量部分有小幅但显著的延长,而对晚期部分无变化。毒毛花苷使早期结束的电图有显著延长,令人惊讶的是,它显著缩短了对照状态下QRS复合波中结束较晚的电图的结束时间。然而,这种效应在体表并未体现出来,因为毒毛花苷对QRS复合波的早期或晚期部分均无显著影响。得出的结论是,通过QRS复合波终末部分更大程度的延长,在体表检测到了普鲁卡因胺对早期和晚期结束的电图的差异作用。信号平均的体表QRS复合波在检测利多卡因和毒毛花苷对传导产生的更细微影响方面不太敏感。(摘要截选至400字)